Simulations Plus (SLP) 6.28 $SLP
Simulations Plus Q1 revenues up 50%
Seeking Alpha - at Seeking Alpha - Wed Dec 03, 3:34PM CST
SLP: 6.28 (-0.01)
Simulations Plus Reports First Quarter FY2015 Preliminary Revenues
Business Wire - Wed Dec 03, 7:30AM CST
Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, today reported preliminary revenues for its first quarter of fiscal year 2015 ended November 30, 2014 (1QFY15).
SLP: 6.28 (-0.01)
Simulations Plus (SLP) CEO Walt Woltosz on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue Nov 25, 10:04PM CST
SLP: 6.28 (-0.01)
Simulations Plus posts 4Q profit
Automated Insights - Tue Nov 25, 4:16PM CST
LANCASTER, Calif. (AP) _ Simulations Plus Inc. (SLP) on Tuesday reported net income of $223,000, or 1 cent per share, in its fiscal fourth quarter.
SLP: 6.28 (-0.01)
Simulations Plus EPS of $0.01
Seeking Alpha - at Seeking Alpha - Tue Nov 25, 3:29PM CST
SLP: 6.28 (-0.01)
Simulations Plus Reports FY2014 and Fourth Quarter FY2014 Financial Results
Business Wire - Tue Nov 25, 3:01PM CST
Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of software for pharmaceutical discovery and development, today reported its financial results for its 2014 fiscal year (FY14) and fourth quarter (4Q14) ended August 31, 2014.
SLP: 6.28 (-0.01)
Simulations Plus to Attend The Benchmark Company, LLC's Micro Cap Discovery Conference in Chicago on December 11
Business Wire - Mon Nov 24, 7:45AM CST
Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of consulting services and software for pharmaceutical discovery and development, today announced that Walt Woltosz, Chairman and Chief Executive Officer, and Ted Grasela, President, will attend The Benchmark Company, LLC's Micro Cap Discovery Conference on Thursday, Dec. 11, 2014. The one-on-one conference will be held at The Palmer House Hilton, 17 E. Monroe St., Chicago, IL, from 8 a.m. to 2:30 p.m. Please email slp@haydenir.com or contact your Benchmark representative to schedule a one-on-one meeting.
SLP: 6.28 (-0.01)
Simulations Plus to Present at the LD MICRO Conference in Los Angeles on December 3
Business Wire - Mon Nov 24, 7:30AM CST
Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of consulting services and software for pharmaceutical discovery and development, today announced that Walt Woltosz, Chairman and Chief Executive Officer, will present at the LD MICRO Conference on Wednesday, December 3, 2014, at 2:30 p.m. PST in Track 1. The conference will be held Dec. 2-4, 2014, at the Luxe Sunset Boulevard Hotel, 11461 Sunset Blvd., Los Angeles, California. The Company's presentation will be available for the public to access via its corporate website, www.simulations-plus.com or at http://wsw.com/webcast/ldmicro7/slp. This webcast will be archived for 90 days following the live presentation. Simulations Plus management will be available during the day on Dec. 3 for one-on-one meetings. Please contact LD MICRO to schedule a meeting.
SLP: 6.28 (-0.01)
Simulations Plus Sets Date for 4th Quarter and Fiscal Year 2014 Earnings Release and Conference Call
Business Wire - Tue Nov 18, 7:30AM CST
Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of software and consulting services for pharmaceutical R&D and environmental toxicology, announced that it expects to file its annual report on Form 10-K for the 2014 fiscal year ended August 31, 2014, with the U.S. Securities and Exchange Commission by Monday, December 1, 2014. Dr. Ted Grasela, president, and Walt Woltosz, chairman and CEO, will host a conference call to discuss the Company's performance on Tuesday, November 25, 2014, at 1:15 p.m. PST / 4:15 p.m. EST.
SLP: 6.28 (-0.01)
Simulations Plus Announces Changes in Board of Directors
Business Wire - Wed Nov 05, 7:02AM CST
Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, today announced that a member of its Board of Directors has elected to retire from the board and a new, outside member has been elected to fill the vacancy.
SLP: 6.28 (-0.01)
Simulations Plus: Riding A 20% Plus Growth Industry
The Double or Nothing Trader - at Seeking Alpha - Tue Nov 04, 11:03AM CST
SLP: 6.28 (-0.01)
Simulations Plus declares $0.05 dividend
Seeking Alpha - at Seeking Alpha - Tue Oct 28, 7:11AM CDT
SLP: 6.28 (-0.01)
Simulations Plus Announces Quarterly Cash Dividend of $0.05 Per Share
Business Wire - Tue Oct 28, 7:01AM CDT
Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, today announced that its board of directors has declared its next ongoing quarterly cash dividend of $0.05 per share to its shareholders. This cash dividend will be distributed on Friday, November 14, 2014, for shareholders of record as of Friday, November 7, 2014.
SLP: 6.28 (-0.01)
Simulations Plus Software licensed by Dow for toxicology, environmental research
M2 - Tue Oct 28, 5:40AM CDT
Simulations Plus, Inc. (NASDAQ: SLP) said that The Dow Chemical Company (NYSE: DOW) has licensed both its best-in-class GastroPlus and ADMET Predictor software programs.
SLP: 6.28 (-0.01), DOW: 43.35 (-2.66)
Dow Chemical Licenses Simulations Plus Software to Assist with Toxicology and Environmental Research
Business Wire - Mon Oct 27, 7:00AM CDT
Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of software for discovery and development, announced that The Dow Chemical Company (NYSE: DOW) has licensed both its best-in-class GastroPlus(TM) and ADMET Predictor(TM) software programs.
SLP: 6.28 (-0.01), DOW: 43.35 (-2.66)
Simulations Plus Adds to Portfolio with Release of MembranePlus
Business Wire - Tue Oct 21, 7:02AM CDT
Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of consulting services and software for pharmaceutical discovery and development, today announced that it has expanded its product portfolio with the release of version 1.0 of its MembranePlus(TM) simulation software.
SLP: 6.28 (-0.01)
Nasdaq stocks posting largest percentage decreases
AP - Thu Oct 09, 5:02PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
GLNG: 34.68 (-1.63), SLP: 6.28 (-0.01), TILE: 15.92 (+0.17), EOPN: 7.57 (-0.11), ARWR: 5.76 (-0.17), DGLY: 15.55 (+1.34), SZYM: 2.25 (-0.09), KFX: 6.56 (-0.09)
Shares of SLP Up 13.1% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Wed Oct 01, 9:27AM CDT
SmarTrend identified an Uptrend for Simulations Plus (NASDAQ:SLP) on August 5th, 2014 at $6.15. In approximately 2 months, Simulations Plus has returned 13.10% as of today's recent price of $6.95.
SLP: 6.28 (-0.01)
Uptrend Call Working As Simulations Plus Stock Rises 13.9% (SLP)
Comtex SmarTrend(R) - Fri Sep 19, 5:00PM CDT
SmarTrend identified an Uptrend for Simulations Plus (NASDAQ:SLP) on August 5th, 2014 at $6.15. In approximately 2 month, Simulations Plus has returned 13.91% as of today's recent price of $7.00.
SLP: 6.28 (-0.01)
Simulations Plus Q1 revenues up 50%
Seeking Alpha - at Seeking Alpha - Wed Dec 03, 3:34PM CST
SLP: 6.28 (-0.01)
Simulations Plus Reports First Quarter FY2015 Preliminary Revenues
Business Wire - Wed Dec 03, 7:30AM CST
Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, today reported preliminary revenues for its first quarter of fiscal year 2015 ended November 30, 2014 (1QFY15).
SLP: 6.28 (-0.01)
Simulations Plus (SLP) CEO Walt Woltosz on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue Nov 25, 10:04PM CST
SLP: 6.28 (-0.01)
Simulations Plus posts 4Q profit
Automated Insights - Tue Nov 25, 4:16PM CST
LANCASTER, Calif. (AP) _ Simulations Plus Inc. (SLP) on Tuesday reported net income of $223,000, or 1 cent per share, in its fiscal fourth quarter.
SLP: 6.28 (-0.01)
Simulations Plus EPS of $0.01
Seeking Alpha - at Seeking Alpha - Tue Nov 25, 3:29PM CST
SLP: 6.28 (-0.01)
Simulations Plus Reports FY2014 and Fourth Quarter FY2014 Financial Results
Business Wire - Tue Nov 25, 3:01PM CST
Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of software for pharmaceutical discovery and development, today reported its financial results for its 2014 fiscal year (FY14) and fourth quarter (4Q14) ended August 31, 2014.
SLP: 6.28 (-0.01)
Simulations Plus to Attend The Benchmark Company, LLC's Micro Cap Discovery Conference in Chicago on December 11
Business Wire - Mon Nov 24, 7:45AM CST
Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of consulting services and software for pharmaceutical discovery and development, today announced that Walt Woltosz, Chairman and Chief Executive Officer, and Ted Grasela, President, will attend The Benchmark Company, LLC's Micro Cap Discovery Conference on Thursday, Dec. 11, 2014. The one-on-one conference will be held at The Palmer House Hilton, 17 E. Monroe St., Chicago, IL, from 8 a.m. to 2:30 p.m. Please email slp@haydenir.com or contact your Benchmark representative to schedule a one-on-one meeting.
SLP: 6.28 (-0.01)
Simulations Plus to Present at the LD MICRO Conference in Los Angeles on December 3
Business Wire - Mon Nov 24, 7:30AM CST
Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of consulting services and software for pharmaceutical discovery and development, today announced that Walt Woltosz, Chairman and Chief Executive Officer, will present at the LD MICRO Conference on Wednesday, December 3, 2014, at 2:30 p.m. PST in Track 1. The conference will be held Dec. 2-4, 2014, at the Luxe Sunset Boulevard Hotel, 11461 Sunset Blvd., Los Angeles, California. The Company's presentation will be available for the public to access via its corporate website, www.simulations-plus.com or at http://wsw.com/webcast/ldmicro7/slp. This webcast will be archived for 90 days following the live presentation. Simulations Plus management will be available during the day on Dec. 3 for one-on-one meetings. Please contact LD MICRO to schedule a meeting.
SLP: 6.28 (-0.01)
Simulations Plus Sets Date for 4th Quarter and Fiscal Year 2014 Earnings Release and Conference Call
Business Wire - Tue Nov 18, 7:30AM CST
Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of software and consulting services for pharmaceutical R&D and environmental toxicology, announced that it expects to file its annual report on Form 10-K for the 2014 fiscal year ended August 31, 2014, with the U.S. Securities and Exchange Commission by Monday, December 1, 2014. Dr. Ted Grasela, president, and Walt Woltosz, chairman and CEO, will host a conference call to discuss the Company's performance on Tuesday, November 25, 2014, at 1:15 p.m. PST / 4:15 p.m. EST.
SLP: 6.28 (-0.01)
Simulations Plus Announces Changes in Board of Directors
Business Wire - Wed Nov 05, 7:02AM CST
Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, today announced that a member of its Board of Directors has elected to retire from the board and a new, outside member has been elected to fill the vacancy.
SLP: 6.28 (-0.01)
Simulations Plus: Riding A 20% Plus Growth Industry
The Double or Nothing Trader - at Seeking Alpha - Tue Nov 04, 11:03AM CST
SLP: 6.28 (-0.01)
Simulations Plus declares $0.05 dividend
Seeking Alpha - at Seeking Alpha - Tue Oct 28, 7:11AM CDT
SLP: 6.28 (-0.01)
Simulations Plus Announces Quarterly Cash Dividend of $0.05 Per Share
Business Wire - Tue Oct 28, 7:01AM CDT
Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, today announced that its board of directors has declared its next ongoing quarterly cash dividend of $0.05 per share to its shareholders. This cash dividend will be distributed on Friday, November 14, 2014, for shareholders of record as of Friday, November 7, 2014.
SLP: 6.28 (-0.01)
Simulations Plus Software licensed by Dow for toxicology, environmental research
M2 - Tue Oct 28, 5:40AM CDT
Simulations Plus, Inc. (NASDAQ: SLP) said that The Dow Chemical Company (NYSE: DOW) has licensed both its best-in-class GastroPlus and ADMET Predictor software programs.
SLP: 6.28 (-0.01), DOW: 43.35 (-2.66)
Dow Chemical Licenses Simulations Plus Software to Assist with Toxicology and Environmental Research
Business Wire - Mon Oct 27, 7:00AM CDT
Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of software for discovery and development, announced that The Dow Chemical Company (NYSE: DOW) has licensed both its best-in-class GastroPlus(TM) and ADMET Predictor(TM) software programs.
SLP: 6.28 (-0.01), DOW: 43.35 (-2.66)
Simulations Plus Adds to Portfolio with Release of MembranePlus
Business Wire - Tue Oct 21, 7:02AM CDT
Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of consulting services and software for pharmaceutical discovery and development, today announced that it has expanded its product portfolio with the release of version 1.0 of its MembranePlus(TM) simulation software.
SLP: 6.28 (-0.01)
Nasdaq stocks posting largest percentage decreases
AP - Thu Oct 09, 5:02PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
GLNG: 34.68 (-1.63), SLP: 6.28 (-0.01), TILE: 15.92 (+0.17), EOPN: 7.57 (-0.11), ARWR: 5.76 (-0.17), DGLY: 15.55 (+1.34), SZYM: 2.25 (-0.09), KFX: 6.56 (-0.09)
Shares of SLP Up 13.1% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Wed Oct 01, 9:27AM CDT
SmarTrend identified an Uptrend for Simulations Plus (NASDAQ:SLP) on August 5th, 2014 at $6.15. In approximately 2 months, Simulations Plus has returned 13.10% as of today's recent price of $6.95.
SLP: 6.28 (-0.01)
Uptrend Call Working As Simulations Plus Stock Rises 13.9% (SLP)
Comtex SmarTrend(R) - Fri Sep 19, 5:00PM CDT
SmarTrend identified an Uptrend for Simulations Plus (NASDAQ:SLP) on August 5th, 2014 at $6.15. In approximately 2 month, Simulations Plus has returned 13.91% as of today's recent price of $7.00.
SLP: 6.28 (-0.01)
